Sentinel Asset Management’s Novartis NVS Stock Holding History

Sentinel Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-360,580	Closed	-$27.5M	–	256
2014 Q1	$27.5M	Hold	360,580	–	–	0.54%	71
2013 Q4	$26M	Hold	360,580	–	–	0.5%	79
2013 Q3	$24.8M	Hold	360,580	–	–	0.52%	75
2013 Q2	$22.8M	Buy	+360,580	New	+$23.5M	0.49%	75

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sentinel Asset Management's NVS Position: Q2 2014 in Review

Sentinel Asset Management sold out of Novartis (NVS) in Q2 2014, closing a stake of 360,580 shares — an estimated $27.5M sold.

Sentinel Asset Management first reported a position in NVS in Q2 2013 and held it in 4 quarters. The position peaked at $27.5M in Q1 2014. 848 funds tracked by Wall St. Rank hold NVS as of Q2 2014.

Sentinel Asset Management reported no remaining Novartis position as of Q2 2014 after selling out during the quarter.
Sentinel Asset Management sold 360,580 Novartis shares in Q2 2014, an estimated $27.5M.
Sentinel Asset Management first reported a position in Novartis in Q2 2013 and held it in 4 quarters.
Sentinel Asset Management's Novartis position peaked at $27.5M in Q1 2014.
848 funds tracked by Wall St. Rank held Novartis as of Q2 2014.

Based on Sentinel Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.